Irritable Bowel Syndrome Trial, Recruiting NCT03687814 Sponsor: University of Michigan Condition: Irritable Bowel Syndrome
Back to Irritable Bowel Syndrome

Irritable Bowel Syndrome Trial, Recruiting

NCT03687814
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are 18 years of age or older.
  • You have been diagnosed with or meet the criteria for IBS with constipation (IBS-C), meaning you have recurring stomach pain at least one day per week on average over the past 3 months, and that pain is linked to going to the bathroom, changes in how often you have bowel movements, or changes in the hardness or shape of your stools (more hard/lumpy stools than loose ones).

Who may not be able to join:

  • You have a type of IBS other than the constipation type (IBS-C).
  • You had more than 3 spontaneous (unassisted) bowel movements in the last 7 days of the study's run-in period.
  • You have difficulty with thinking or understanding, or are unable to read and sign a consent form.
  • You are pregnant (based on self-reporting).
  • You have inflammatory bowel disease (such as Crohn's disease or ulcerative colitis).
  • You have a condition outside the gut that is known to affect digestion or bowel function, such as scleroderma or an unstable thyroid condition (confirm with trial site).
  • You have serious kidney or liver disease.
  • You have had abdominal surgery in the past, unless it was an appendix removal, gallbladder removal, or a gynecological or urological procedure performed more than six months before joining the trial.
  • You have previously followed a low FODMAP diet with the guidance of a dietitian.
  • You are currently taking probiotics, antibiotics, prescription or over-the-counter IBS medications, or narcotic pain medications.
  • You have recently started taking an antidepressant and have not yet been on a stable dose for at least 3 months.
  • You are currently taking part in another type of dietary therapy or program.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Stacy B Menees, MD, MS, University of Michigan

Phone: 734-232-3739

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
8 November 2018
Est. completion
1 January 2026

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Improvement of abdominal pain as measured by 11-point numerical rating scale

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov